Avadel Pharmaceuticals plc (AVDL)
USD 10.33
(-3.73%)
USD 10.33
(-3.73%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 35.38 Million USD | -72.99% |
| 2022 | 131.02 Million USD | -9.64% |
| 2021 | 145 Million USD | 11.09% |
| 2020 | 130.52 Million USD | 4.71% |
| 2019 | 124.65 Million USD | 7.61% |
| 2018 | 115.84 Million USD | 43285.77% |
| 2017 | 267 Thousand USD | -67.24% |
| 2016 | 815 Thousand USD | -27.1% |
| 2015 | 1.11 Million USD | -99.06% |
| 2014 | 118.48 Million USD | 38.25% |
| 2013 | 85.7 Million USD | 132.35% |
| 2012 | 36.88 Million USD | 807.83% |
| 2011 | 4.06 Million USD | 0.17% |
| 2010 | 4.05 Million USD | 3.87% |
| 2009 | 3.9 Million USD | 25.24% |
| 2008 | 3.11 Million USD | -8.94% |
| 2007 | 3.42 Million USD | -1.81% |
| 2006 | 3.48 Million USD | -8.02% |
| 2005 | 3.79 Million USD | 29.39% |
| 2004 | 2.93 Million USD | 33.61% |
| 2003 | 2.19 Million USD | -10.93% |
| 2002 | 2.46 Million USD | 45.17% |
| 2001 | 1.69 Million USD | -23.6% |
| 2000 | 2.22 Million USD | -15.85% |
| 1999 | 2.63 Million USD | -20.52% |
| 1998 | 3.31 Million USD | -2.38% |
| 1997 | 3.4 Million USD | 61.9% |
| 1996 | 2.1 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 36.73 Million USD | 3.82% |
| 2024 Q2 | 37.66 Million USD | 2.54% |
| 2023 Q4 | 35.38 Million USD | 47.24% |
| 2023 Q1 | 115.16 Million USD | -12.1% |
| 2023 Q3 | 24.03 Million USD | 8.62% |
| 2023 FY | 35.38 Million USD | -72.99% |
| 2023 Q2 | 22.12 Million USD | -80.79% |
| 2022 Q4 | 131.02 Million USD | -5.24% |
| 2022 FY | 131.02 Million USD | -9.64% |
| 2022 Q1 | 145.12 Million USD | 0.08% |
| 2022 Q2 | 136.51 Million USD | -5.94% |
| 2022 Q3 | 138.27 Million USD | 1.29% |
| 2021 Q3 | 144.05 Million USD | 0.13% |
| 2021 Q4 | 145 Million USD | 0.66% |
| 2021 Q1 | 143.66 Million USD | 10.07% |
| 2021 FY | 145 Million USD | 11.09% |
| 2021 Q2 | 143.85 Million USD | 0.14% |
| 2020 FY | 130.52 Million USD | 4.71% |
| 2020 Q1 | 126.06 Million USD | 1.14% |
| 2020 Q2 | 127.52 Million USD | 1.16% |
| 2020 Q3 | 129 Million USD | 1.16% |
| 2020 Q4 | 130.52 Million USD | 1.18% |
| 2019 Q3 | 124.62 Million USD | 1.04% |
| 2019 Q1 | 122.15 Million USD | 5.45% |
| 2019 FY | 124.65 Million USD | 7.61% |
| 2019 Q4 | 124.65 Million USD | 0.02% |
| 2019 Q2 | 123.35 Million USD | 0.98% |
| 2018 Q2 | 113.14 Million USD | 1.17% |
| 2018 Q1 | 111.83 Million USD | 41786.89% |
| 2018 Q4 | 115.84 Million USD | 1.18% |
| 2018 Q3 | 114.48 Million USD | 1.19% |
| 2018 FY | 115.84 Million USD | 43285.77% |
| 2017 Q2 | 885 Thousand USD | 7.01% |
| 2017 Q4 | 267 Thousand USD | -70.82% |
| 2017 FY | 267 Thousand USD | -67.24% |
| 2017 Q1 | 827 Thousand USD | 1.47% |
| 2017 Q3 | 915 Thousand USD | 3.39% |
| 2016 Q3 | 1.02 Million USD | -4.76% |
| 2016 Q4 | 815 Thousand USD | -20.1% |
| 2016 Q2 | 1.07 Million USD | -7.99% |
| 2016 FY | 815 Thousand USD | -27.1% |
| 2016 Q1 | 1.16 Million USD | 4.11% |
| 2015 FY | 1.11 Million USD | -99.06% |
| 2015 Q1 | 123.18 Million USD | 3.97% |
| 2015 Q2 | 149.68 Million USD | 21.51% |
| 2015 Q4 | 1.11 Million USD | 0.0% |
| 2014 Q3 | 95.95 Million USD | 9.54% |
| 2014 Q4 | 118.48 Million USD | 23.48% |
| 2014 Q2 | 87.59 Million USD | 17.07% |
| 2014 FY | 118.48 Million USD | 38.25% |
| 2014 Q1 | 74.82 Million USD | -12.7% |
| 2013 Q1 | 54.25 Million USD | 47.09% |
| 2013 Q2 | 84.98 Million USD | 56.65% |
| 2013 Q3 | 85.96 Million USD | 1.15% |
| 2013 Q4 | 85.7 Million USD | -0.31% |
| 2013 FY | 85.7 Million USD | 132.35% |
| 2012 Q4 | 36.88 Million USD | 0.0% |
| 2012 Q2 | 50.1 Million USD | -0.16% |
| 2012 FY | 36.88 Million USD | 807.83% |
| 2012 Q1 | 50.18 Million USD | 1135.12% |
| 2011 FY | 4.06 Million USD | 0.17% |
| 2011 Q1 | 4.45 Million USD | 9.84% |
| 2011 Q2 | 4.15 Million USD | -6.71% |
| 2011 Q3 | 4.19 Million USD | 0.94% |
| 2011 Q4 | 4.06 Million USD | -3.15% |
| 2010 Q1 | 3.64 Million USD | -6.63% |
| 2010 FY | 4.05 Million USD | 3.87% |
| 2010 Q4 | 4.05 Million USD | 1.0% |
| 2010 Q3 | 4.01 Million USD | 10.97% |
| 2010 Q2 | 3.61 Million USD | -0.74% |
| 2009 Q3 | 3.21 Million USD | 3.38% |
| 2009 Q4 | 3.9 Million USD | 21.5% |
| 2009 FY | 3.9 Million USD | 25.24% |
| 2009 Q1 | 2.93 Million USD | -5.9% |
| 2009 Q2 | 3.1 Million USD | 5.96% |
| 2008 Q3 | 3.24 Million USD | -10.54% |
| 2008 FY | 3.11 Million USD | -8.94% |
| 2008 Q1 | 3.56 Million USD | 4.23% |
| 2008 Q2 | 3.62 Million USD | 1.54% |
| 2008 Q4 | 3.11 Million USD | -3.82% |
| 2007 FY | 3.42 Million USD | -1.81% |
| 2007 Q4 | 3.42 Million USD | 0.26% |
| 2007 Q3 | 3.41 Million USD | 1.67% |
| 2007 Q2 | 3.35 Million USD | -1.61% |
| 2007 Q1 | 3.41 Million USD | -2.09% |
| 2006 Q3 | 3.45 Million USD | -3.14% |
| 2006 Q4 | 3.48 Million USD | 1.07% |
| 2006 Q2 | 3.56 Million USD | -0.97% |
| 2006 Q1 | 3.59 Million USD | -5.12% |
| 2006 FY | 3.48 Million USD | -8.02% |
| 2005 Q2 | 2.81 Million USD | -9.78% |
| 2005 FY | 3.79 Million USD | 29.39% |
| 2005 Q4 | 3.79 Million USD | -15.08% |
| 2005 Q3 | 4.46 Million USD | 58.69% |
| 2005 Q1 | 3.11 Million USD | 6.42% |
| 2004 Q4 | 2.93 Million USD | 31.74% |
| 2004 Q3 | 2.22 Million USD | 0.0% |
| 2004 FY | 2.93 Million USD | 33.61% |
| 2004 Q1 | 2.09 Million USD | -4.61% |
| 2004 Q2 | 2.22 Million USD | 6.31% |
| 2003 FY | 2.19 Million USD | -10.93% |
| 2003 Q4 | 2.19 Million USD | 19.97% |
| 2003 Q2 | 1.88 Million USD | 1.89% |
| 2003 Q1 | 1.85 Million USD | -24.82% |
| 2003 Q3 | 1.82 Million USD | -3.08% |
| 2002 Q3 | 2.05 Million USD | 0.0% |
| 2002 FY | 2.46 Million USD | 45.17% |
| 2002 Q4 | 2.46 Million USD | 20.1% |
| 2001 Q4 | 1.69 Million USD | 0.0% |
| 2001 FY | 1.69 Million USD | -23.6% |
| 2000 Q4 | 2.22 Million USD | 0.0% |
| 2000 FY | 2.22 Million USD | -15.85% |
| 1999 Q4 | 2.63 Million USD | 0.0% |
| 1999 FY | 2.63 Million USD | -20.52% |
| 1998 Q4 | 3.31 Million USD | 0.0% |
| 1998 Q1 | 3.3 Million USD | -2.94% |
| 1998 FY | 3.31 Million USD | -2.38% |
| 1997 FY | 3.4 Million USD | 61.9% |
| 1997 Q4 | 3.4 Million USD | 0.0% |
| 1996 Q4 | 2.1 Million USD | 0.0% |
| 1996 FY | 2.1 Million USD | 0.0% |
| 1996 Q1 | 2 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Theratechnologies Inc. | 58.96 Million USD | 39.995% |
| Harrow Health, Inc. | 190.5 Million USD | 81.426% |
| Dynavax Technologies Corporation | 256.91 Million USD | 86.227% |
| Biofrontera Inc. | 5.39 Million USD | -555.381% |
| Cronos Group Inc. | 2.53 Million USD | -1293.105% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -5719.737% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 95.055% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | 2.585% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -2916.523% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -92.007% |
| Radius Health, Inc. | 365.31 Million USD | 90.314% |
| Universe Pharmaceuticals INC | 5.48 Million USD | -545.404% |
| DURECT Corporation | 20.74 Million USD | -70.558% |
| ProPhase Labs, Inc. | 21.38 Million USD | -65.5% |
| Safety Shot Inc | 1.54 Million USD | -2184.351% |
| Phibro Animal Health Corporation | 525.45 Million USD | 93.266% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -1236.529% |
| Alvotech | 1.07 Billion USD | 96.71% |
| Assertio Holdings, Inc. | 40.91 Million USD | 13.512% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | 14.793% |
| Rockwell Medical, Inc. | 13.43 Million USD | -163.293% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -5279.92% |
| Procaps Group S.A. | 285.93 Million USD | 87.625% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | -108.903% |
| SCYNEXIS, Inc. | 15.08 Million USD | -134.642% |
| Aytu BioPharma, Inc. | 15.12 Million USD | -133.882% |
| Viatris Inc. | 18.12 Billion USD | 99.805% |
| OptiNose, Inc. | 131.74 Million USD | 73.143% |
| SIGA Technologies, Inc. | 1.46 Million USD | -2316.925% |
| Tilray Brands, Inc. | 387.31 Million USD | 90.864% |
| PetIQ, Inc. | 468.3 Million USD | 92.444% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -5279.92% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 91.74% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Alimera Sciences, Inc. | 67.39 Million USD | 47.501% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 94.752% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -3153.121% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 70.353% |
| Journey Medical Corporation | 17.73 Million USD | -99.571% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | -327.519% |
| Alpha Teknova, Inc. | 30.45 Million USD | -16.173% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | -1595.448% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 72.857% |
| PainReform Ltd. | 86 Thousand USD | -41044.186% |
| Cosmos Health Inc. | 12.42 Million USD | -184.805% |
| TherapeuticsMD, Inc. | 8 Million USD | -342.024% |
| Embecta Corp. | 1.63 Billion USD | 97.84% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -59063.643% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 93.962% |
| Incannex Healthcare Limited | 373 Thousand USD | -9386.327% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -3324.982% |
| Shineco, Inc. | 29.65 Million USD | -19.313% |
| Procaps Group, S.A. | 285.93 Million USD | 87.625% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 88.779% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | 64.194% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 94.265% |
| Alvotech | 1.07 Billion USD | 96.71% |
| Hempacco Co., Inc. | 13.72 Million USD | -157.816% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | 43.355% |
| Bright Green Corporation | 1.85 Million USD | -1810.807% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 93.459% |
| Kamada Ltd. | 8.74 Million USD | -304.435% |
| Indivior PLC | 281.6 Million USD | 87.435% |
| Evoke Pharma, Inc. | 5 Million USD | -607.68% |
| Flora Growth Corp. | 3.67 Million USD | -863.617% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -3324.982% |
| Evolus, Inc. | 126.54 Million USD | 72.039% |
| HUTCHMED (China) Limited | 86.13 Million USD | 58.918% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 94.326% |
| Akanda Corp. | 3.99 Million USD | -784.867% |